Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T14:15:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T13:24:50.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access to the study record is blocked. This reflects an access issue rather than an update to the study details.
    Difference
    19%
    Check dated 2026-09-20T19:44:14.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This reflects a new revision/version of the page content but does not alter the study details themselves.
    Difference
    0.1%
    Check dated 2026-08-30T15:34:05.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.4 to v3.6.5, indicating a new version of the page. This reflects a maintenance update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:35:00.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, replacing the previous revision. This appears to be a metadata update with no changes to the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-25T12:55:44.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.